NDC 70518-2780-1 - Naloxone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2780
- Requested NDC
- 70518-2780-1
- Package NDCs from labels
- 70518-2780-1, 70518-2780-0
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naloxone Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70518-2780-0 | 2022-02-02 | C162847 | 48780-1 | d6a99b39-47e2-a426-e053-dadaa90af4c2 | 4838e624-7b53-4e45-b42c-ef1213507188 |
| 70518-2780-0 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-47e2-a426-e053-dadaa90af4c2 | 4838e624-7b53-4e45-b42c-ef1213507188 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | ProPharma Distribution | 3f2bb95a-aeca-c0b7-e063-6394a90a627b | 2025-09-19 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e6467385-6990-498c-8a0e-f4a40ef33cb7 | 2025-09-02 | Warnings, Adverse reactions | 1191250 F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | AMERISOURCE BERGEN | cce38c13-0d2f-49bb-94fa-6f2bbb4d5984 | 2025-08-31 | Warnings | F850569PQR |
| PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Lupin Pharmaceuticals,Inc. | 017ef042-40aa-44c9-baa8-037f06356845 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | F850569PQR |
| KLOXXADO | NALOXONE HCL | Hikma Specialty USA Inc. | ebf0f833-c1c0-487c-8f29-01fa8c61b6cb | 2025-08-25 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 3ba53405-5e72-c035-e063-6294a90ac0b1 | 2025-08-05 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 201fdedf-1736-4e52-9d7d-de14292547fd | 2025-07-31 | Warnings, Adverse reactions | 1191250 F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | ProPharma Distribution | 3856ea66-29b8-8fc2-e063-6394a90ac33a | 2025-07-18 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Eugia US LLC | 8bcf426a-b4fc-4f24-9ad0-fb26168a0b56 | 2025-05-14 | Warnings, Adverse reactions | 1191250 F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | NorthStar RxLLC | d4c44b74-4e36-4b63-80eb-64ce99ccb39f | 2025-01-27 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 9bcff682-1196-7cef-e053-2a95a90aa954 | 2025-01-08 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | International Medication Systems, Limited | 236349ef-2cb5-47ca-a3a5-99534c3a4996 | 2024-12-16 | Warnings, Adverse reactions | ANDA072076 1191250 F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 28f3e3bc-b1be-9f06-e063-6394a90a1936 | 2024-12-10 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Asclemed USA, Inc. | 7acf3bde-f858-4fbc-8a11-6741a3d27b8e | 2024-10-29 | Warnings | F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | Baxter Healthcare Corporation | 48137634-91d7-41e3-b54b-e4321d69668a | 2024-10-04 | Warnings, Adverse reactions | 1191250 F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Bryant Ranch Prepack | ed549649-dcbd-41f7-a774-876906751c5a | 2024-10-03 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Eugia US LLC | c7fa8d4f-28a7-4ef5-aef8-cbd4328ce599 | 2024-07-06 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Eugia US LLC | 2725b9c0-5b1e-498b-9ec5-ee76a62e656a | 2024-07-06 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 1be2e38b-55ca-abea-e063-6394a90ac548 | 2024-06-27 | Warnings | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 19b0603b-241f-f439-e063-6294a90ae85f | 2024-05-30 | Warnings | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.